The prevalence of myopia is projected to increase from approximately two billion people worldwide in 2010 to almost five billion people in 2050 bringing with it near- and long-term health challenges.
In fact, the proportion of young people with myopia in the UK has more than doubled over the last 50 years, in those aged between 10–16 years and children are becoming myopic at a younger age.
“Myopia’s growth has been dizzying, and now affects the vast majority of young adults in some countries, especially in East Asia,” said Arthur Back, Chief Technology Officer for CooperVision and a leading voice on myopia management. “Not only does it create blurred vision, but also increases the likelihood of conditions later in life such as glaucoma, cataract, retinal detachment and myopic maculopathy if not addressed.”
Coopervision are now announcing groundbreaking new solutions to Mypoia Management Therapy which may be beneficial to Children with Myopia for more information on their findings read the full article here